© kentoh dreamstime.com Electronics Production | September 05, 2016
Insulet updates materials supplier deal with Flextronics
Flextronics Medical Sales and Marketing has entered into a materials supplier agreement with Insulet.
Under the new agreement, which has an initial term of five years, Flextronics will continue to produce and manufacture the company’s proprietary Omnipod Insulin Management System, as well as the Insulet’s drug delivery devices and personal diabetes managers (PDMs). Manufacturing by Flextronics of the devices will continue to be done at a facility in China owned and operated by a subsidiary of Flextronics, according to a SEC-filing made by Insulet.